Clinical Trial Update: Individualization of Ganciclovir and Valganciclovir Doses Using Bayesian Prediction in Renal Transplant Patients. [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated Bayesian-prediction-based dosing of ganciclovir and valganciclovir in renal transplant patients to individualize therapy for infect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infection in Solid Organ Transplant Recipients

Drugs mentioned

• Cytovene (ganciclovir)
• Valcyte (valganciclovir)

Snippet

Sponsor: Nuria Lloberas | Conditions: Infection in Solid Organ Transplant Recipients | Phase 4 | Status: COMPLETED